з/п не указана
Introducing Health Technology Assessment in Ukraine (HTA Consultant vacancy)
December 29, 2018
In September 2017, United States Agency for International Development (USAID) awarded a five-year Health Safe, Affordable, and Effective Medicines (SAFEMed) contract to the Management Sciences for Health (MSH). SAFEMed applies health system-strengthening best practices to create evidence-based interventions and strengthen Ukraine’s pharmaceutical system in line with the Ministry of Health’s (MOH) health care reform objectives. SAFEMed seeks to improve access to appropriate, quality medicines to maximize availability within MOH’s budgetary constraints. SAFEMed interventions will institutionalize rational medicine selection, strengthen and systematize public procurement of pharmaceuticals and commodities, support sustainable public sector pharmaceutical financing, and strengthen the pharmaceutical supply chain in collaboration with the Government of Ukraine (GOU), the MOH and the National Health Service of Ukraine (NHSU), civil society partners, other implementing partners, and the private sector. By the end of SAFEMed, Ukraine’s pharmaceutical system will be more transparent and cost efficient and availability of medicines will increase, thereby supporting the GOU goal of a health care system that produces desired health outcomes.
SAFEMed implementation focuses on high-priority areas that have the potential to make significant contributions to the development of the pharmaceutical system in Ukraine and to support PEPFAR’s priorities of transparent and cost-effective procurement of HIV commodities, incorporation of HIV commodities into the program of medical guarantees, and efficient supply chain management, quantification, and forecasting to support the scale-up of testing and treatment.
In pursuit of its goal, SAFEMed has three primary project objectives:
Health policy priority setting is a key focus for SAFEMed and encompasses the development of HTA capability in Ukraine along with the governance and institutional structures required to operationalize the concept. Over the course of January – September 2019, SAFEMed will work on re-evaluation of the work already completed by the project previously and development of an updated roadmap with the relevant stakeholders, including harmonizing the different views of HTA within the MOH and State Expert Center, selected by the Ministry of Health to carry an interim HTA agency function.
The overall purpose of this short-term consultancy is to contribute to the development of the HTA function in Ukraine under guidance and oversight of SAFEMed Senior Technical Advisor.
Over the course of this consultancy, consult will report directly to Ms. Rabia Kahveci, SAFEMed Senior Technical Advisor.
Duties performance location
Duration of duties performance
Proposed duration of this short-term consultancy is from February 1 until September 20, 2019.
Interested qualified candidates can send their CVs and motivation letter till January 18, 2019. Only shortlisted applicants will be contacted.